Company intelligence / Profile preview

Pelagos Pharmaceuticals

Houston, Texas, United Statespelagospharma.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

No published clinical results. The company operates in stealth mode and focuses on developing next-generation inflammasome therapeutics and drugs that mimic the beneficial effects of acute aerobic exercise through metabolic/mitochondrial pathway activation.

Therapeutic areas: Metabolic DisordersCardiovascular
Modalities: Small molecules
Industry: Biotech

Partnerships

Mercury Fund investor relationship noted, but no major pharma partnerships disclosed yet

Beyond the preview

Go deeper on Pelagos Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pelagos Pharmaceuticals.

Explore the full profile